Hwamin Lin
Director/Board Member at REDHORSE GROUP CO.LTD.
Profile
Hwamin Lin is currently an Independent Director at Redhorse Group Co. Ltd.
and Youhua Biotechnology Pharmaceutical Co. Ltd.
He previously worked as a Senior Manager at WK Technology Fund and as Deputy President at Jingyuan Trading Co. Ltd.
Lin holds an MBA from Keio University.
Hwamin Lin active positions
Companies | Position | Start |
---|---|---|
REDHORSE GROUP CO.LTD. | Director/Board Member | 2017-06-05 |
Youhua Biotechnology Pharmaceutical Co. Ltd. | Director/Board Member | - |
Former positions of Hwamin Lin
Companies | Position | End |
---|---|---|
WK Technology Fund
WK Technology Fund Investment ManagersFinance WK Technology Fund invests in technology companies located in the US and Taiwan. The fund targets companies operating in the fields of communications, semiconductor, IT, medical instruments and clean energy sectors. It provides financing for early and later stage capital requirements with an initial investment size in the range of $1 - $10 million. | Corporate Officer/Principal | - |
Jingyuan Trading Co. Ltd. | Corporate Officer/Principal | - |
Training of Hwamin Lin
Keio University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Redhorse Group Co. Ltd.
Redhorse Group Co. Ltd. Internet RetailRetail Trade Redhorse Group Co. Ltd. operates as a holding company, which engages in the provision of travel related services. Its offers souvenir mail order catalogs service and travel goods retail. The company was founded in 1964 and is headquartered in Hong Kong. | Retail Trade |
Jingyuan Trading Co. Ltd. | |
WK Technology Fund
WK Technology Fund Investment ManagersFinance WK Technology Fund invests in technology companies located in the US and Taiwan. The fund targets companies operating in the fields of communications, semiconductor, IT, medical instruments and clean energy sectors. It provides financing for early and later stage capital requirements with an initial investment size in the range of $1 - $10 million. | Finance |
Youhua Biotechnology Pharmaceutical Co. Ltd. |
- Stock Market
- Insiders
- Hwamin Lin